A carregar...
Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
Alemtuzumab is a humanized monoclonal antibody directed against CD52 to deplete circulating T and B lymphocytes; lymphocyte depletion is followed by a distinctive pattern of T- and B-cell repopulation, changing the balance of the immune system. This review reports the efficacy and safety findings of...
Na minha lista:
| Publicado no: | Mult Scler |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361497/ https://ncbi.nlm.nih.gov/pubmed/25344374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458514549398 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|